Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Healthcare Industry News NeoGenomics launches PanTracer Tissue and HRD-enhanced profiling to accelerate ovarian cancer treatment decisions NeoGenomics launches PanTracer Tissue and PanTracer Tissue + HRD to fast-track ovarian cancer treatment with next-gen genomic profiling and rapid HRD testing. byPallavi MadhirajuJuly 2, 2025